Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma

MLA

Izumi, Miiru, et al. “Diagnostic Value of Bone-Turnover Metabolites in the Diagnosis of Bone Metastases in Patients with Lung Carcinoma.” Cancer, vol. 91, no. 8, Apr. 2001, pp. 1487–93. EBSCOhost, https://doi.org/10.1002/1097-0142(20010415)91:8<1487::AID-CNCR1156>3.0.CO;2-2.

APA

Izumi, M., Nakanishi, Y., Takayama, K., Kimotsuki, K., Inoue, K., Wataya, H., Minami, T., & Hara, N. (2001). Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma. Cancer, 91(8), 1487–1493. https://doi.org/10.1002/1097-0142(20010415)91:8<1487::AID-CNCR1156>3.0.CO;2-2

Chicago

Izumi, Miiru, Yoichi Nakanishi, Koichi Takayama, Kanehito Kimotsuki, Koji Inoue, Hiroshi Wataya, Takahiro Minami, and Nobuyuki Hara. 2001. “Diagnostic Value of Bone-Turnover Metabolites in the Diagnosis of Bone Metastases in Patients with Lung Carcinoma.” Cancer 91 (8): 1487–93. doi:10.1002/1097-0142(20010415)91:8<1487::AID-CNCR1156>3.0.CO;2-2.